Arch Therapeutics Inc (ARTH)

[ramspower]

I'm trying to sort through it too. I went back to the November 2016 Prospectus and found the exercise price of the Series D warrants is $0.25, so the holder is currently in the money. If I'm reading this right, there are 10,906,663 shares tied to the Series D Warrants. If and when the holder exercises the warrants, this would bring in additional cash of $2.7 million dollars to Arch's balance sheet and extend the runway into calendar year 2020 as we wait for CE Mark approval.


"This prospectus relates to the offering and resale by the selling securityholders of Arch Therapeutics, Inc. named herein of up to 16,531,508 shares of common stock, par value $0.001 per share (“Common Stock”). These shares include the 5,624,845 shares of issued and outstanding Common Stock currently held by the selling securityholders and 10,906,663 shares of Common Stock currently underlying Series D Warrants held by the selling securityholders, all of which were initially issued and sold in a private placement offering that was concluded on July 2, 2015 (the “2015 Private Placement Financing”). The Common Stock issued in the 2015 Private Placement Financing was sold as a part of a unit (“Unit”) consisting of a share of our Common Stock and a Series D Warrant at a purchase price of $0.22 per Unit. The Series D Warrants entitle the holders thereof to purchase a share of Common Stock at an initial exercise price of $0.25 per share, were exercisable immediately upon issuance and expire five years thereafter."